The Evolving Landscape of Immunotherapy-Based Combinations for Frontline Treatment of Advanced Renal Cell Carcinoma

Insights into the biology of advanced renal cell carcinoma (aRCC) and the development of agents targeting the vascular endothelial growth factor (VEGF) pathway have positively impacted the outcomes for patients with aRCC. With the recent approval of the dual immune checkpoint inhibitors (ICIs), nivo...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Asim Amin, Hans Hammers
Médium: Artigo
Jazyk:Inglês
Vydáno: Frontiers Media S.A. 2019-01-01
Edice:Frontiers in Immunology
Témata:
combination immunotherapy
VEGF inhibition
immune check point inhibitor
advanced renal cell carcinoma
immuno modulation
On-line přístup:https://www.frontiersin.org/article/10.3389/fimmu.2018.03120/full
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky